Newtyn Management’s Forte Biosciences FBRX Stock Holding History

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Shares Change %	Capital Flow	Portfolio Weight	Portfolio Position
2023 Q2	–	Sell	-16,430	Closed	-$415K	–	59
2023 Q1	$415K	Sell	16,430 -5,520	-25%	-$139K	0.08%	71
2022 Q4	$549K	Buy	21,950 +1,950	+10%	+$48.8K	0.11%	62
2022 Q3	$535K	Buy	+20,000	New	+$535K	0.12%	65